EDMONTON, Alberta, Aug. 23 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that interest in its VScan Dengue Fever kit continues to increase. Originally, the Company had projected that it would sell approximately 250,000 VScan Dengue Fever tests in the latest fiscal year. Based on independent inquiries and orders from distributors the Company has increased its projections for Dengue Fever test kits to 400,000. While not a significant number of kits, it will generate substantial cashflow. The number of countries indicating that Dengue Fever is a becoming a problem is growing each year. As the accuracy of the VScan Dengue Fever test kit becomes known, the number of test kits required will increase. The Company is in a position to take advantage of the growth. In most countries, it takes 3 to 6 weeks to get test results due to the specialized testing equipment required. The Dengue Fever kit gives results in 20 minutes and costs less than 15% of any current test. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV1&2, Tuberculosis (TB), Hepatitis B&C, Dengue Fever, West Nile, Syphilis. Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/. NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright